← Evidence map

ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2024

CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance.

Muhammad Shahzad Rafiq et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38605260